Relapse markers in multiple sclerosis: Are in vitro cytokine production changes reflected by circulatory T-cell phenotype alterations?

Multiple Sclerosis

Volumn 4, Issue 3, 1998, Pages 193-197

  Debruyne, Jan ^a   Philippé, Jan ^a   Dereuck, Jacques ^a   Willems, Annick ^a   Leroux Roels, Geert ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Interferon ; Interleukin 2; Multiple sclerosis; Neopterin; T lymphocyte subpopulations; Tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; NEOPTERIN; OKT 3; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; HUMAN; MALE; MONOCYTE; MULTIPLE SCLEROSIS; NORMAL HUMAN; PATIENT MONITORING; PHENOTYPE; RELAPSE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0031680513     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859800400320     Document Type: Article

References (21)

1. Philippé J et al. (1996) In vitro TNF-α. IL-2 and IFN-γ production as markers of relapses in multiple sclerosis. Clin Neurol Neurosurg 98: 286 - 290.
2. Martin R, McFarland HF, McFarlin DE. (1992) Immunological aspects of demyelinating diseases. Annu Rev Immunol 10: 153 - 187.
3. Panitch HS, Sever CTJ, Katz E, Johnson KP. (1991) Upper respiratory infections trigger attacks of multiple sclerosis in patients treated with interferon-β. J Neuroimmunol 35 (Suppl. 1): 125 (abstract).
4. Sibley WA, Bamford CR, Clark K. (1985) Clinical viral infections and multiple sclerosis. Lancet i: 1313 - 1315.
5. Yednock TA et al. (1992) Prevention of experimental auto-immune encephalomyelitis by antibodies against α4β1 integrin. Nature 356: 63 - 66.
6. Haahr S, Moller-Larsen A, Justesen J, Petersen E. (1986) Interferon induction, 2′-5′ oligo A synthetase and lymphocyte subpopulations in out-patients with multiple sclerosis in a longitudinal study. Acta Neurol Scand 73: 345 - 351.
7. Beck J et al. (1988) Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations? Acta Neurol Scand 78: 318 - 323.
8. Chofflon M et al. (1992) Tumor necrosis factor α production as a possible predictor of relapse in patients with multiple sclerosis. Eur Cytokine Netw 3: 523 - 531.
9. Probert L et al. (1995) Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor α. Proc Natl Acad Sci 92: 11294 - 11298.
10. Shoedon G, Troppmair F, Adolf G, Huber C. Niederwieser A. (1986) Interferon-gamma enhances biosynthesis of neopterins in peripheral blood mononuclear cells by induction of GTP-cyclohydrolase I activity. J Interferon Res 6: 697 - 703.
11. 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis. J Neurol 241: 108 - 114.
12. Poser CM et al. (1983) New diagnostic criteria for Multiple Sclerosis: guidelines for research protocols. Ann Neurol 13: 227 - 231.
13. Kurtzke J. (1983) Rating neurological impairment in MS: an Expanded Disability Status Scale (EDSS). Neurology 33: 1444 - 1452.
14. Rieckmann P et al. (1995) Tumor necrosis factor-alpha messenger expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 37: 82 - 88.
15. Harris JO. (1991) Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol 29: 548 - 555.
16. Olsson T. (1994) Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis. Eur J Neurol 1: 7 - 19.
17. Rieckmann P et al. (1994) Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse. Neurology 44: 2367 - 2372.
18. Zaffaroni M et al. (1990) Decrease of CD4+CD45+ T-cells in chronic-progressive multiple sclerosis. J Neurol 237: 1 - 4.
19. Eoli M et al. (1993) Presence of T-cell subset abnormalities in newly diagnosed cases of multiple sclerosis and relationship with short-term clinical activity. J Neurol 240: 79 - 82.
20. Kronfol Z, Turner R, House JD, Winokur G. (1986) Elevated blood neutrophil concentration in mania. J Clin Pyschiatry 47: 63 - 67.
21. Podikoglou DG, Lianou PE, Tsankanikas CD, Papavassiliou JT. (1994) Polymorphonuclear leukocyte functions and multiple sclerosis. Neurology 44: 129 - 132.